DongKook Pharmaceutical Co. Ltd (086450) — Net Asset Quality Index
DongKook Pharmaceutical Co. Ltd (086450) has a Net Asset Quality Index of 71.5% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩1.09 Trillion minus total liabilities of ₩310.75 Billion yields net assets of ₩780.60 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See 086450 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
DongKook Pharmaceutical Co. Ltd Net Asset Quality Index Over Time (2013–2025)
This chart shows how DongKook Pharmaceutical Co. Ltd's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the index stands at 71.5%, representing net assets of ₩780.60 Billion against total assets of ₩1.09 Trillion KRW. Explore DongKook Pharmaceutical Co. Ltd (086450) cash conversion ratio to assess how effectively this company generates cash.
Annual Net Asset Quality Index for DongKook Pharmaceutical Co. Ltd (2013–2025)
The table below presents the year-by-year Net Asset Quality Index for DongKook Pharmaceutical Co. Ltd from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see DongKook Pharmaceutical Co. Ltd stock valuation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 71.9% | ₩763.74 Billion | ₩1.06 Trillion | ₩299.16 Billion | ▲ +0.6 pp |
| 2024 | 71.2% | ₩678.98 Billion | ₩953.16 Billion | ₩274.19 Billion | ▲ +2.6 pp |
| 2023 | 68.6% | ₩576.17 Billion | ₩839.54 Billion | ₩263.36 Billion | ▲ +3.3 pp |
| 2022 | 65.3% | ₩501.94 Billion | ₩768.33 Billion | ₩266.39 Billion | ▲ +4.7 pp |
| 2021 | 60.6% | ₩454.57 Billion | ₩750.08 Billion | ₩295.51 Billion | ▼ -1.4 pp |
| 2020 | 62.0% | ₩411.37 Billion | ₩663.17 Billion | ₩251.80 Billion | ▼ -4.6 pp |
| 2019 | 66.7% | ₩362.87 Billion | ₩544.38 Billion | ₩181.51 Billion | ▲ +1.5 pp |
| 2018 | 65.2% | ₩313.02 Billion | ₩480.24 Billion | ₩167.22 Billion | ▼ -5.5 pp |
| 2017 | 70.7% | ₩263.94 Billion | ₩373.31 Billion | ₩109.37 Billion | ▼ -2.3 pp |
| 2016 | 73.0% | ₩237.32 Billion | ₩325.10 Billion | ₩87.78 Billion | ▲ +0.4 pp |
| 2015 | 72.6% | ₩199.62 Billion | ₩274.80 Billion | ₩75.18 Billion | ▲ +0.3 pp |
| 2014 | 72.3% | ₩176.57 Billion | ₩244.17 Billion | ₩67.60 Billion | ▼ -2.0 pp |
| 2013 | 74.3% | ₩162.24 Billion | ₩218.26 Billion | ₩56.02 Billion | — |